book chapter · Advances in computational intelligence and robotics book series
Pharmaceutical supply chains face regulatory, logistical, and transparency challenges. AI integration offers transformative solutions, enhancing demand forecasting, inventory management, and logistics efficiency. While AI improves operational resilience and risk mitigation, adoption barriers—data privacy, regulatory complexity, and costs—persist. Collaboration among stakeholders (pharma firms, tech providers, policymakers) is vital to address technical, ethical, and compliance gaps. Prioritizing scalable AI tools and partnerships can overcome these hurdles, fostering agile, transparent supply networks. Strategic AI adoption strengthens global medication access, healthcare outcomes, and supply chain sustainability. This study highlights AI's urgency in building resilient pharma operations amid evolving market demands and patient needs.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4018/979-8-3373-6645-6.ch001
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
